检测到您当前使用浏览器版本过于老旧,会导致无法正常浏览网站;请您使用电脑里的其他浏览器如:360、QQ、搜狗浏览器的极速模式浏览,或者使用谷歌、火狐等浏览器。
学术报告
Title:Broad H3K4me3 Reveals Increased Transcription Elongation and Enhancer Activity at Tumor Suppressors
Speaker: Kaifu Chen
Division of Biostatistics
Department of Molecular and Cellular Biology
Baylor College of Medicine
Time: 13:30-14:30 PM, April 9, 2014 (Thu.)
Venue: Rm. 311, New Life Sciences Building
Tumor suppressors are mostly defined by inactivating somatic mutations in tumors, yet little is known about their epigenetic features in normal cells. Here, through integrative analysis of 1,134 genome-wide epigenetic profiles and mutations from >8,200 tumor-normal pairs, we discovered broad H3K4me3 (wider than 4 kb) as the first epigenetic signature for tumor suppressors in normal cells. Broad H3K4me3 is associated with increased transcription elongation and enhancer activity, which together lead to exceptionally high gene expression. Inhibiting transcription elongation causes H3K4me3 shortening. Broad H3K4me3 conserved across normal cells or tissues represents a set of core tumor suppressors, such as P53 and PTEN, whereas cell-type-specific broad H3K4me3 indicates cell-identity genes and cell-type-specific tumor suppressors. Furthermore, widespread shortening of broad H3K4me3 in cancers is strongly associated with repression of tumor suppressors. Cellular validation indicates that 87.5% of tumor suppressor candidates defined based on conserved broad H3K4me3 sigfinicantly suppress tumor cell growth. Together, the broad H3K4me3 epigenetic signature we reported here provide a new direction for the discovery and characterization of novel tumor suppressors.
欢迎各位老师同学积极参加!